AusPAR: Nadroparin

Australian Public Assessment Report

AusPAR

Australian Public Assessment Report for Nadroparin [PDF, 649.99 KB]

Australian Public Assessment Report for Nadroparin [Word, 909.73 KB]

Attachment: Product Information: Nadroparin [PDF, 176.47 KB]

Attachment: Product Information: Nadroparin [Word, 80.64 KB]

Attachment: Extract from Clinical Evaluation: Nadroparin [PDF, 829.43 KB]

Attachment: Extract from Clinical Evaluation: Nadroparin [Word, 1.26 MB]

Device/Product Name

Fraxiparine

Active ingredients

Nadroparin

AusPAR Date

4 September 2018

Published

4 October 2018

Submission Number

PM-2016-02215-1-3

Submission Type

Extension of indications

Decision

Approved